For: | Cao B, Chen XP, Zhu P, Ding L, Guan J, Shi ZL. Inhibitory effect of interferon-α-2b on expression of cyclooxygenase-2 and vascular endothelial growth factor in human hepatocellular carcinoma inoculated in nude mice. World J Gastroenterol 2008; 14(44): 6802-6807 [PMID: 19058305 DOI: 10.3748/wjg.14.6802] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i44/6802.htm |
Number | Citing Articles |
1 |
Nicholas Brodszki, John‐Kalle Länsberg, Michael Dictor, Erik Gyllstedt, Sven‐Börje Ewers, Marcus K Larsson, Erik A Eklund. A novel treatment approach for paediatric Gorham–Stout syndrome with chylothorax. Acta Paediatrica 2011; 100(11): 1448 doi: 10.1111/j.1651-2227.2011.02361.x
|
2 |
Larissa Widholzer Galant, Ângelo Alves de Mattos, Eduardo Menti, Fabiana Borba Valiatti, Ângelo Zambam de Mattos, Marilene Porawski, Antônio Hartmann, Cláudia Ramos Rhoden. The effect of celecoxib on the development of diethylnitrosamine-induced liver tumors in rats. Annals of Hepatology 2013; 12(3): 425 doi: 10.1016/S1665-2681(19)31005-1
|
3 |
Mehrdad Afarid, Hossein Bahari, Fatemeh Sanie-Jahromi. In Vitro Evaluation of Apoptosis, Inflammation, Angiogenesis, and Neuroprotection Gene Expression in Retinal Pigmented Epithelial Cell Treated with Interferon α-2b. Journal of Interferon & Cytokine Research 2023; 43(7): 299 doi: 10.1089/jir.2023.0028
|
4 |
Jianhong He, Quanbao Zhang, Zhijian Ren, Yumin Li, Xun Li, Wence Zhou, Hui Zhang, Wenbo Meng, Jun Yan, Wenting He. Cyclooxygenase-2 −765 G/C polymorphisms and susceptibility to hepatitis B-related liver cancer in Han Chinese population. Molecular Biology Reports 2012; 39(4): 4163 doi: 10.1007/s11033-011-1199-y
|
5 |
Ece Turan-Vural,, Banu Torun Acar, Suphi Acar. The Efficacy of Topical Interferon Alpha 2b Treatment in Refractory Vernal Keratoconjunctivitis. Ocular Immunology and Inflammation 2012; 20(2): 125 doi: 10.3109/09273948.2012.656877
|
6 |
Jonathan Charles, Andrea Vrionis, Arian Mansur, Trevor Mathias, Jamil Shaikh, Aaron Ciner, Yixing Jiang, Nariman Nezami. Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies. Cancers 2023; 15(9): 2624 doi: 10.3390/cancers15092624
|
7 |
Inna G. Stroh, Lilangi S. Ediriwickrema, Neil R. Miller. Gorham–Stout Disease Presenting as Acute Unilateral Proptosis. Journal of Neuro-Ophthalmology 2018; 38(1): 70 doi: 10.1097/WNO.0000000000000569
|
8 |
Mark W Russo. Antiviral therapy for hepatitis C is associated with improved clinical outcomes in patients with advanced fibrosis. Expert Review of Gastroenterology & Hepatology 2010; 4(5): 535 doi: 10.1586/egh.10.60
|
9 |
Mark W. Russo. The Role of Interferon Therapy in Patients with Hepatocellular Carcinoma. Current Hepatitis Reports 2012; 11(4): 279 doi: 10.1007/s11901-010-0075-x
|
10 |
Eun-Kyoung Kim, Dong-Sup Chung, Hye-jin Shin, Yong-Kil Hong. Inhibitory Effect of IFN-β, on the Antitumor Activity of Celecoxib in U87 Glioma Model. Journal of Korean Neurosurgical Society 2009; 46(6): 552 doi: 10.3340/jkns.2009.46.6.552
|
11 |
Eileen M. Bauer, Han Zheng, Michael T. Lotze, Philip M. Bauer, You-Yang Zhao. Recombinant Human Interferon Alpha 2b Prevents and Reverses Experimental Pulmonary Hypertension. PLoS ONE 2014; 9(5): e96720 doi: 10.1371/journal.pone.0096720
|
12 |
Mark W. Russo. Erratum to: The Role of Interferon Therapy in Patients With Hepatocellular Carcinoma. Current Hepatitis Reports 2009; 8(S1): 35 doi: 10.1007/s11901-011-0088-0
|
13 |
Jean-Louis Dupond, Laurent Bermont, Michel Runge, Marjolaine de Billy. Plasma VEGF determination in disseminated lymphangiomatosis–Gorham–Stout syndrome: A marker of activity? A case report with a 5-year follow-up. Bone 2010; 46(3): 873 doi: 10.1016/j.bone.2009.11.015
|
14 |
Soon Ha Kwon, Soung Won Jeong, Jae Young Jang, Ji Eun Lee, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, So-Young Jin. Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma. Clinical and Molecular Hepatology 2012; 18(3): 287 doi: 10.3350/cmh.2012.18.3.287
|
15 |
Kai Zhu, Zhi Dai, Jian Zhou. Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy. Biomarker Research 2013; 1(1) doi: 10.1186/2050-7771-1-10
|